ELAB (PMGC Holdings) Research & Development: $0.16 Mil (TTM As of Mar. 2026)


ELAB PMGC Holdings Inc ELAB
8 GF Score
Price $1.25
! 1 Warning Sign
View Full Analysis

What is PMGC Holdings Research & Development?

PMGC Holdings ELAB -5.32% 8 Research & Development is $0.16 Mil as of Mar. 2026. GuruFocus rates ELAB with a GF Score™ of 8/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PMGC Holdings's Research & Development for the three months ended in Mar. 2026 was $0.05 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.16 Mil.

PMGC Holdings  (NAS:ELAB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PMGC Holdings Research & Development Related Terms

PMGC Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for PMGC Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PMGC Holdings Research & Development Chart

PMGC Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.12 0.23 0.01 0.11 0.15

PMGC Holdings Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.07 0.02 0.03 0.05
ELAB
8GF Score
PMGC Holdings Inc ELAB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PMGC Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.16 Mil mean?
PMGC Holdings (ELAB) has a Research & Development of $0.16 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PMGC Holdings and its competitors.
Is PMGC Holdings' Research & Development too high?
PMGC Holdings' current Research & Development is $0.16 Mil. Overall, PMGC Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PMGC Holdings' Research & Development compare to SYBX and CNSP?
PMGC Holdings' Research & Development of $0.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PMGC Holdings and its competitors. PMGC Holdings's current Research & Development is $0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMGC Holdings stock overvalued right now?
PMGC Holdings (ELAB) has a current Research & Development of $0.16 Mil. The current Research & Development is $0.16 Mil. PMGC Holdings' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PMGC Holdings (ELAB), the current Research & Development is $0.16 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMGC Holdings Business Description

Address C/O 120 Newport Center Drive, Suite 250, Newport Beach, CA, USA, 92660
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
8GF Score

Get the complete analysis for ELAB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.25
Price